Zinterl Carolina, Costa-Reis Patrícia, Esteves Isabel Castro, Marques José Gonçalo, Sousa Ana Berta, Fonseca João Eurico, Oliveira Ramos Filipa
Pediatric Rheumatology Unit, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal.
Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Centro Académico de Medicina de Lisboa, Lisbon, Portugal.
J Multidiscip Healthc. 2022 May 4;15:999-1010. doi: 10.2147/JMDH.S351546. eCollection 2022.
Systemic autoinflammatory diseases (SAID) are characterized by inappropriate activation of the innate immune system and include not only monogenic periodic fever syndromes but also multifactorial conditions. As SAID are rare and represent a diagnostic challenge, a multidisciplinary approach is important to ensure successful diagnosis and adequate follow-up of these patients.
To describe the organization of our multidisciplinary SAID clinic and to characterize our clinical experience, highlighting the benefits of multidisciplinary team management.
Our SAID clinic takes place monthly and is managed by pediatric rheumatologists closely collaborating with pediatricians specialized in infectious diseases and immunodeficiencies and one medical geneticist. Patients' data are systematically incorporated in the Rheumatic Diseases Portuguese Register (Reuma.pt). Biological samples are stored in a biobank. We describe our clinical experience based on SAID patients registered into Reuma.pt/SAID between July 2011 and June 2020.
We have registered 176 patients, with a median age of disease onset of 3.1 ± 4.4 years and median age at disease diagnosis of 4.7 ± 4.0 years. Most patients were diagnosed with periodic fever, aphthous stomatitis, pharyngitis, adenitis syndrome (PFAPA) (n=133), 20 with undefined SAID (uSAID) and 13 with monogenic SAID, including familial Mediterranean fever (FMF) (n=5), tumor necrosis factor receptor-associated periodic syndrome (TRAPS) (n=1), cryopyrin-associated periodic disease (CAPS) (n=1), and hyperimmunoglobulin D syndrome/mevalonate kinase deficiency (HIDS/MKD) (n=2). A genetic test was performed in 31 patients (18%), and in 26% of these a mutation responsible for the phenotype was found. Thirty-four patients (19%) achieved remission.
FMF was the most common monogenic SAID and the percentage of patients with an identified causal mutation was low. A structured electronic clinical record coupled with a biobank and a multidisciplinary approach are crucial to ensure successful diagnosis and adequate follow-up of these patients.
系统性自身炎症性疾病(SAID)的特征是先天性免疫系统的不适当激活,不仅包括单基因周期性发热综合征,还包括多因素疾病。由于SAID较为罕见且诊断具有挑战性,多学科方法对于确保这些患者的成功诊断和充分随访至关重要。
描述我们多学科SAID诊所的组织情况,并阐述我们的临床经验,突出多学科团队管理的益处。
我们的SAID诊所每月开诊一次,由儿科风湿病学家与专门从事传染病和免疫缺陷的儿科医生以及一名医学遗传学家密切合作管理。患者数据被系统地纳入葡萄牙风湿病登记册(Reuma.pt)。生物样本存储在生物库中。我们基于2011年7月至2020年6月期间登记在Reuma.pt/SAID中的SAID患者描述我们的临床经验。
我们登记了176例患者,疾病发病的中位年龄为3.1±4.4岁,疾病诊断时的中位年龄为4.7±4.0岁。大多数患者被诊断为周期性发热、口疮性口炎、咽炎、腺炎综合征(PFAPA)(n = 133),20例为未明确的SAID(uSAID),13例为单基因SAID,包括家族性地中海热(FMF)(n = 5)、肿瘤坏死因子受体相关周期性综合征(TRAPS)(n = 1)、冷吡啉相关周期性疾病(CAPS)(n = 1)和高免疫球蛋白D综合征/甲羟戊酸激酶缺乏症(HIDS/MKD)(n = 2)。31例患者(18%)进行了基因检测,其中26%发现了导致该表型的突变。34例患者(19%)实现缓解。
FMF是最常见的单基因SAID,已确定致病突变的患者比例较低。结构化的电子临床记录、生物库和多学科方法对于确保这些患者的成功诊断和充分随访至关重要。